Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT

导出原文传递

翻译打印收藏纠错

作者： Takano, K. ^[1] ; Fuji, S. ^[2] ; Uchida, N. ^[3] ; Ogawa, H. ^[4] ; Ohashi, K. ^[5] ; Eto, T. ^[6] ; Sakamaki, H. ^[7] ; Morishima, Y. ^[8] ; Kato, K. ; Suzuki, R. ; Fukuda, T.

作者单位： Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan ^[1] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management Biostat, Nagoya, Aichi 4648601, Japan ^[2] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Tokyo 1040045, Japan ^[3] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan ^[4] Hyogo Coll Med, Dept Internal Med, Div Hematol, Kobe, Hyogo, Japan ^[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan ^[6] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan ^[7] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol Oncol, Nagoya, Aichi, Japan ^[8]

发布时间 2015-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Bone marrow transplantation

2015年50卷4期

553-558页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

检索历史清除